West Pharmaceutical Services (WST) Current Leases (2019 - 2026)

West Pharmaceutical Services has disclosed Current Leases across 8 years of filings, most recently posting $20.9 million for Q2 2026.

• In Q2 2026, Current Leases changed 0.0% year-over-year to $20.9 million; the TTM figure through Jun 2026 stood at $20.9 million (changed 0.0% YoY), while the FY2025 annual figure was $22.7 million, up 26.82% from the prior year.
• Current Leases came in at $20.9 million for Q2 2026 at West Pharmaceutical Services, down from $21.4 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $22.7 million in Q4 2025 to a low of $9.8 million in Q1 2022.
• Average Current Leases over 5 years is $17.8 million, with a median of $18.0 million recorded in 2024.
• Year-over-year, Current Leases surged 72.04% in 2022 and fell 1.83% in 2026.
• Over 5 years, Current Leases stood at $16.0 million in 2022, then rose by 10.62% to $17.7 million in 2023, then grew by 1.13% to $17.9 million in 2024, then climbed by 26.82% to $22.7 million in 2025, then declined by 7.93% to $20.9 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $20.9 million in Q2 2026, $21.4 million in Q1 2026, and $22.7 million in Q4 2025.